Foraviset Welcomes Prof. Tasuku Harada to Advisory Board – Foraviset
Foraviset shared a post on LinkedIn:
“We are pleased and honored to announce yet another outstanding addition to Foraviset’s expanding Scientific Advisory Board: Prof. Tasuku Harada, President of Tottori University, Japan.
It’s hard to capture Prof. Harada’s career in a single post – but a few highlights speak for themselves:
- President, Tottori University (2025– )
- Vice President, Tottori University (2023-2025)
- Director, Tottori University Hospital (2017-2023)
- Professor, Obstetrics and Gynecology, Tottori University Faculty of Medicine (2008-2023)
Prof. Harada is also the former President of the Japan Society of Endometriosis and the Asian Society of Endometriosis and Adenomyosis (ASEA), and has held board roles with the World Endometriosis Society (WES) and the Society of Endometriosis and Uterine Disorders (SEUD).
Prof. Harada graduated from Tottori University in 1983, and trained in IVF-ET at the University of Leeds (UK) in 1985.
He has (co)authored 220+ peer-reviewed publications. He also served as chief investigator in the drug development of eight therapies for endometriosis and dysmenorrhea in Japan, and edited the Springer book ‘Endometriosis Pathogenesis and Treatment’ (2014).
As a member of Foraviset’s Scientific Advisory Board, Prof. Harada will contribute strategic scientific and clinical guidance, support trial readiness, and help strengthen the academic rigor behind our non-hormonal approach to endometriosis and broader uterine health.
We are proud to welcome Prof. Harada at this pivotal stage of our journey.”
Uri Dior, Co-Chief Medical Officer at Foraviset, shared a post, adding:
“Very excited to be joined, on our Scientific Advisory Board, by the esteemed Prof. Tasuku Harada, an inspiring leader in the research and treatment of endometriosis. Welcome.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Mar 1, 2026, 16:41Exploring Frozen and Fresh Embryo Transfer Risks – Fertility and Sterility
-
Mar 1, 2026, 16:35Cressida Bradley: Navigating AI Challenges in Endometriosis Diagnosis
-
Mar 1, 2026, 16:33Abhishek Kumar: Next-Gen Insights on Antiphospholipid Syndrome Care
-
Mar 1, 2026, 16:31Alan Murray: The Legacy of Innovation in Reproductive Medicine
-
Mar 1, 2026, 16:24Elevate Your ART Skills at ESHRE’s Ultrasound Workshop – ESHRE
-
Mar 1, 2026, 16:22Recognizing Contributions of Women in Science This February – ASRM
-
Mar 1, 2026, 04:32Fertility Preservation Options for Turner Syndrome Explored – Fertility and Sterility
-
Feb 28, 2026, 03:58Juan M. Hincapie-Castillo: FDA Releases Draft 2026 Guidance Plans Including Endometriosis-Associated Pain
-
Feb 28, 2026, 03:45Deepak Modi: Elated to Share Our Preprint on a New Placenta on Chip Model